The Research and Development team at QuellTX is dedicated to pioneering the development of engineered T-regulatory cell therapies. This multidisciplinary team, composed of scientists and specialists in process development, quality control, and translational medicine, focuses on innovative research and rigorous testing to advance therapeutic solutions for solid organ transplants and autoimmune diseases. Their work encompasses everything from discovery and new technologies to process optimization, ensuring that QuellTX remains at the forefront of Treg cell therapy innovation.
View all